Insider · CIK 0001410677

Divis Gregory J

Reports to the SEC for 3 companies · DUBLIN 2, L2

sec.gov

Transactions

Companies

Filings

CIK

0001410677

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−150K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−100K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−100K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−10K sh	$21.00	−$210K	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−310K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−211K sh	$21.00	−$4.43M	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−600K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−350K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−310K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−500K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−400K sh	—	—	0
2025-03-05	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director, Chief Executive Officer	AAward	+52K sh	—	—	211,100
2025-03-05	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+310K sh	—	—	310,000
2024-12-09	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+402 sh	$9.82	+$3,947.64	10,000
2024-12-06	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+9,598 sh	$9.98	+$95.8K	9,598
2024-02-20	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+600K sh	—	—	600,000
2023-08-10	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$13.20	+$132K	159,100
2023-06-05	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+350K sh	—	—	350,000
2022-05-27	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+50K sh	$2.05	+$102K	149,100
2022-05-18	JAGXJaguar Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.1K sh	—	—	12,133
2022-05-18	JAGXJaguar Health, Inc. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−12.1K sh	—	—	0
2022-03-28	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director	AAward	+85.9K sh	—	—	85,900
2021-12-07	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+310K sh	—	—	310,000
2021-05-18	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director	AAward	+72.8K sh	—	—	72,750
2021-05-18	JAGXJaguar Health, Inc. · Restricted stock unitsA Award	Director	AAward	+36.4K sh	—	—	36,400
2020-12-08	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000
2020-08-12	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+13K sh	$7.78	+$101K	99,100
2020-03-20	JAGXJaguar Health, Inc. · Stock option (right to buy)A Award	Director	AAward	+26.5K sh	—	—	26,533
2019-11-15	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+19K sh	$5.13	+$97.5K	86,100
2019-07-24	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director	AAward	+122K sh	—	—	121,573
2019-05-30	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2019-03-07	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director, Chief Executive Officer	AAward	+18K sh	—	—	67,100
2019-03-07	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	$1.85	+$185K	100,000
2018-07-11	JAGXJaguar Health, Inc. · Stock Option (right to buy)A Award	Director	AAward	+105K sh	—	—	104,860
2018-06-26	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+16K sh	$6.00	+$96K	49,100
2018-03-22	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+50K sh	$7.06	+$353K	50,000
2017-12-12	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director, Chief Executive Officer	AAward	+22.5K sh	—	—	33,100
2017-12-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	$8.95	+$895K	100,000
2017-09-12	AVDLAVADEL PHARMACEUTICALS PLCP Purchase	Director, Chief Executive Officer	PPurchase	+10.6K sh	$9.32	+$98.8K	10,600
2013-09-27	K-V Pharmaceutical CoOption to PurchaseA Award	CEO and President	AAward	+80.7K sh	—	—	80,653
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	CEO and President	JOther	−28.8K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	CEO and President	JOther	−70K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	CEO and President	JOther	−50K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	CEO and President	JOther	−10K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	CEO and President	JOther	−70K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoOption to PurchaseJ Other	CEO and President	JOther	−100K sh	—	—	0
2013-09-16	K-V Pharmaceutical CoRestricted Stock UnitsA Award	CEO and President	AAward	+174K sh	—	—	173,611
2013-09-16	K-V Pharmaceutical CoJ Other	CEO and President	JOther	−1,225 sh	—	—	0
2012-03-28	K-V Pharmaceutical CoOption to PurchaseA Award	CEO and President	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Feb 124
Divis Gregory J0001104659-26-014441
SEC(opens sec.gov)
Mar 74
Divis Gregory J0001104659-25-021732
SEC(opens sec.gov)
Dec 104
Divis Gregory J0001104659-24-127300
SEC(opens sec.gov)
Mar 44
Divis Gregory J0001104659-24-030219
SEC(opens sec.gov)
Aug 104
Divis Gregory J0001104659-23-089935
SEC(opens sec.gov)
Jun 54
Divis Gregory J0001104659-23-068234
SEC(opens sec.gov)
May 314
Divis Gregory J0001104659-22-066221
SEC(opens sec.gov)

Companies

Address

C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380